Treatment of erythema nodosum, aphthous stomatitis, and pyoderma gangrenosum in patients with IBD

Inflammatory Bowel Diseases

Volumn 4, Issue 1, 1998, Pages 68-69

  Tremaine, William J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APHTHOUS STOMATITIS; ARTICLE; ENTERITIS; ERYTHEMA NODOSUM; HUMAN; PYODERMA GANGRENOSUM;

ERYTHEMA NODOSUM; HUMANS; INFLAMMATORY BOWEL DISEASES; PYODERMA GANGRENOSUM; STOMATITIS, APHTHOUS;

EID: 0031989337     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-199802000-00010     Document Type: Short Survey

References (3)

1. Sampaio EP, Kaplan G, Miranda A, Nery JA, Miguel CP, Viana SM. The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum. J Infect Dis 1993; 168:408-14.
2. Paterson DL, Georghiou PR, Allworth AM, Kemp RJ. Thalidomide as treatment of refractory aphthous ulceration related to human immunodeficiency virus infection, Clin Infect Dis 1995;20: 250-4.
3. Matis WL, Ellis CN, Griffiths CEM, Lazarus GS. Treatment of pyoderma gangrenosum with cyclosporine. Arch Dermatol 1992; 128:1060-4.